Exploring of Serum Biomarkers of Delirium After Cardiovascular Surgery

Sponsor
Huazhong University of Science and Technology (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06007755
Collaborator
(none)
113
27

Study Details

Study Description

Brief Summary

The incidence of postoperative delirium in patients after cardiovascular surgery is very high, which seriously affects the short-term and long-term prognosis of patients, but its mechanism is not clear. Recent studies have found that lactic acid participates in the process of sepsis by inducing histone lactatation in macrophages. histone H3 lysine 18 lactylation (H3K18la) is significantly associated with the severity of disease and inflammatory response. Inflammation plays an important role in postoperative delirium. We therefore hypothesized that macrophage H3K18la also plays a role in postoperative delirium.At the same time, the latest literature shows that the early markers of Alzheimer's disease (AD), such as exosomes and phosphorylated tau396, 404, etc. [5], can also be detected in the serum of AD patients. Given the obvious correlation between Alzheimer's disease and postoperative delirium [6], we hypothesized that serum phosphorylated exosome and phosphorylated tau396,404 could also be used as serum biomarkers for postoperative delirium.

The objectives of this study were to investigate the correlation between H3K18 in serum monocytes and postoperative delirium and its severity in patients undergoing cardiovascular surgery under cardiopulmonary bypass. Meanwhile, we also detect the serum levels of exosome and phosphorylated tau396,404 in patients undergoing major cardiac surgery. We aim to find the serum biomarkers of delirium after major cardiac surgery, so as to provide a more convenient diagnostic basis for the prevention of postoperative delirium.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    113 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Exploring of Serum Biomarkers of Delirium After Cardiovascular Surgery
    Anticipated Study Start Date :
    Oct 1, 2023
    Anticipated Primary Completion Date :
    Oct 1, 2024
    Anticipated Study Completion Date :
    Dec 31, 2025

    Outcome Measures

    Primary Outcome Measures

    1. Association of H3K18 with postoperative delirium and its severity in patients undergoing cardiovascular surgery under cardiopulmonary bypass [Perioperative data]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    patients who receive elective cardiovascular surgery under cardiopulmonary bypass

    • Patients participated voluntarily and signed informed consent
    Exclusion Criteria:
    • past medical history of neurological and psychiatric diseases; severe visual or hearing impairment;

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Huazhong University of Science and Technology

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hua Zheng, Associate Professor, Huazhong University of Science and Technology
    ClinicalTrials.gov Identifier:
    NCT06007755
    Other Study ID Numbers:
    • TJMZK202301
    First Posted:
    Aug 23, 2023
    Last Update Posted:
    Aug 25, 2023
    Last Verified:
    Aug 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Hua Zheng, Associate Professor, Huazhong University of Science and Technology
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 25, 2023